April 29th, 2019
Starting from today, a new leaflet about Mythocondro® - the Non-Animal Chondroitin Sulfate - is available for our customers.
This new issue has been enriched with the latest scientific updates recently presented in a published clinical human trial (Volpi et al. Clin Pharmacol Drug Dev 2018) on the Bioavailability, Sulfation ΔDi6S and Charge Density of Mythocondro®, compared with a highly pure animal CS. The study on Mythocondro® opens to a decreased dosage of 600 mg/day, which could be formulated in one single dose alternative, once-a-day.
Discover the extensive differences between animal and the branded vegetarian Chondroitin Sulfate (CS) in this new graphic, which clearly guides you to the best choice for supporting joints in total safety. Obtained through a state-of-the-art and patented fermentation-based manufacturing process, with a very low protein content (≤0.5%), low molecular weight and many other features, Mythocondro® always wins versus Animal CS.
Read the new leaflet to learn more!
If you wish to stay updated about Mythocondro® and the other products, click here and subscribe to our newsletter network!